Current ROP Therapies: How Laser and Anti-VEGF Compare
With the publication of the BEAT-ROP study results in 2011, some clinicians were inclined to jump on the bevacizumab bandwagon, while others held back, citing the well-documented success of laser.
What have we learned since then?
EyeNet introduces its brand new mobile-optimized digital edition — all the benefits of the print edition, plus digital enhancements.
Read on a break at work, kicking back at home with our iPad, or on your phone while in line at the grocery store. Check it out.